HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sammy Saab Selected Research

hepatitis B hyperimmune globulin

11/2016The Management of Hepatitis B in Liver Transplant Recipients.
3/2014Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation.
9/2013Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
3/2010Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
4/2009Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.
10/2003Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
5/2002New era of liver transplantation for hepatitis B: a 17-year single-center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sammy Saab Research Topics

Disease

48Hepatitis C
02/2021 - 05/2002
45Infections
11/2022 - 01/2002
41Fibrosis (Cirrhosis)
01/2022 - 05/2002
31Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2003
27Liver Diseases (Liver Disease)
01/2022 - 12/2003
22Hepatitis B
01/2020 - 01/2002
20End Stage Liver Disease
01/2021 - 09/2002
17Neoplasms (Cancer)
01/2019 - 04/2003
16Chronic Hepatitis C
02/2017 - 08/2005
12Hepatitis
01/2022 - 01/2002
9Liver Cirrhosis (Hepatic Cirrhosis)
11/2022 - 09/2011
8Non-alcoholic Fatty Liver Disease
10/2021 - 01/2011
7Hepatic Encephalopathy
01/2022 - 02/2003
7Ascites
01/2021 - 02/2005
6Acute Liver Failure (Fulminant Hepatic Failure)
07/2019 - 05/2003
5Chronic Hepatitis B
01/2020 - 02/2003
5Reinfection
06/2017 - 11/2009
5Obesity
03/2017 - 08/2010
4HIV Infections (HIV Infection)
12/2021 - 08/2005
4Hypertension (High Blood Pressure)
01/2021 - 08/2010
4Alcoholic Fatty Liver
06/2020 - 01/2005
4Liver Failure
12/2018 - 05/2004
4Anemia
06/2017 - 07/2007
3Portal Hypertension
01/2021 - 01/2014
3Hemorrhage
10/2019 - 10/2014
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 10/2016
3Diabetes Mellitus
12/2017 - 09/2007
3Fatty Liver
03/2017 - 01/2004
3Virus Diseases (Viral Diseases)
01/2016 - 11/2011
3Pathologic Constriction (Stenosis)
04/2014 - 06/2009
3Brain Diseases (Brain Disorder)
06/2009 - 02/2005
3Hepatitis A (Hepatitis, Infectious)
04/2009 - 11/2003
2Circulating Neoplastic Cells
01/2022 - 05/2021
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2020 - 12/2017
2Cardiovascular Diseases (Cardiovascular Disease)
06/2020 - 08/2010
2Alcoholic Hepatitis
01/2020 - 08/2018
2Thrombocytopenia (Thrombopenia)
01/2020 - 10/2019
2Chronic Renal Insufficiency
12/2019 - 01/2018
2Proteinuria
07/2019 - 05/2018
2Liver Neoplasms (Liver Cancer)
01/2019 - 09/2011
2Inflammation (Inflammations)
08/2018 - 06/2018
2Heart Failure
01/2018 - 10/2002
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
12/2017 - 03/2011
2Pain (Aches)
12/2016 - 11/2009
2Lymphoma (Lymphomas)
07/2016 - 10/2007
2Neoplasm Metastasis (Metastasis)
07/2016 - 07/2015
2Type 2 Diabetes Mellitus (MODY)
12/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

41Antiviral Agents (Antivirals)IBA
12/2021 - 05/2002
13Ribavirin (Virazole)FDA LinkGeneric
06/2017 - 03/2003
11Immunoglobulins (Immunoglobulin)IBA
12/2019 - 05/2002
10Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2022 - 01/2002
10InterferonsIBA
11/2018 - 08/2005
8sofosbuvir drug combination ledipasvirIBA
12/2018 - 04/2016
8Lamivudine (Epivir)FDA Link
03/2010 - 05/2002
7RNA (Ribonucleic Acid)IBA
12/2021 - 03/2003
7hepatitis B hyperimmune globulinIBA
11/2016 - 05/2002
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 01/2008
6SofosbuvirIBA
11/2017 - 01/2015
5EnzymesIBA
01/2022 - 01/2002
5Alanine Transaminase (SGPT)IBA
10/2021 - 01/2008
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2019 - 12/2004
4SodiumIBA
01/2021 - 05/2006
4CreatinineIBA
12/2019 - 01/2004
4Pharmaceutical PreparationsIBA
01/2019 - 04/2009
4Hepatitis B e AntigensIBA
03/2014 - 01/2008
3Triglycerides (Triacylglycerol)IBA
10/2021 - 12/2006
3Biomarkers (Surrogate Marker)IBA
03/2016 - 06/2009
3Immunosuppressive Agents (Immunosuppressants)IBA
03/2016 - 06/2010
3VaccinesIBA
01/2009 - 11/2003
2LipidsIBA
10/2021 - 06/2018
2Sorafenib (BAY 43-9006)FDA Link
11/2020 - 12/2010
2avatrombopagIBA
01/2020 - 10/2019
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 04/2009
2lusutrombopagIBA
01/2020 - 10/2019
2MTOR InhibitorsIBA
07/2019 - 06/2014
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2018 - 01/2011
2Proteins (Proteins, Gene)FDA Link
05/2018 - 02/2006
2ombitasvirIBA
01/2018 - 01/2015
2paritaprevirIBA
01/2018 - 01/2015
2ledipasvirIBA
11/2017 - 06/2017
2Lactulose (Duphalac)FDA LinkGeneric
04/2017 - 01/2016
2ElectrolytesIBA
07/2016 - 01/2014
2Yttrium-90IBA
07/2016 - 07/2015
2BilirubinIBA
03/2016 - 05/2007
2ErythropoietinFDA Link
09/2015 - 07/2007

Therapy/Procedure

103Liver Transplantation
01/2022 - 05/2002
48Therapeutics
01/2022 - 05/2002
17Transplantation
06/2020 - 10/2002
5Renal Dialysis (Hemodialysis)
02/2019 - 01/2002
4Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2021 - 10/2014
4Transjugular Intrahepatic Portasystemic Shunt
01/2021 - 11/2011
3Patient Readmission
01/2022 - 01/2015
3Length of Stay
10/2019 - 06/2005
3Drug Therapy (Chemotherapy)
09/2013 - 10/2007
2Contraindications
01/2021 - 01/2017
2Fontan Procedure (Fontan Operation)
01/2021 - 01/2018
2Terminal Care (Care, Terminal)
01/2021 - 10/2017
2Radiofrequency Ablation
01/2019 - 05/2005
2Microspheres (Microsphere)
07/2016 - 07/2015
2Radiotherapy
07/2016 - 07/2015